Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CEO Sells 173,225 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 173,225 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the completion of the transaction, the chief executive officer owned 2,650,892 shares of the company’s stock, valued at $19,112,931.32. The trade was a 6.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Jeff Shaner also recently made the following trade(s):

• On Wednesday, February 18th, Jeff Shaner sold 168,800 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.38, for a total value of $1,245,744.00.
• On Tuesday, February 17th, Jeff Shaner sold 119,884 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.65, for a total value of $917,112.60.
• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $233,486.44.

Aveanna Healthcare Stock Up 0.3%

Shares of NASDAQ:AVAH traded up $0.02 during midday trading on Thursday, hitting $7.42. The stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. The company has a market cap of $1.55 billion, a P/E ratio of 20.61 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.67 and a 12 month high of $10.32. The business’s 50-day simple moving average is $8.48 and its 200-day simple moving average is $8.44. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Institutional Trading of Aveanna Healthcare

Several hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after acquiring an additional 25,974 shares during the period. Jane Street Group LLC grew its stake in shares of Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after acquiring an additional 63,010 shares in the last quarter. MQS Management LLC bought a new position in Aveanna Healthcare during the second quarter worth about $59,000. Finally, Belvedere Trading LLC acquired a new stake in Aveanna Healthcare in the 2nd quarter worth about $62,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on AVAH shares. Barclays upped their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a report on Friday, January 16th. William Blair initiated coverage on Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating on the stock. Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Jefferies Financial Group boosted their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a report on Tuesday, October 28th. Finally, Truist Financial increased their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.